PYX-201

DB18382InvestigationalProtein Based Therapies

PYX-201 is an antibody-drug conjugate directed against the extra domain-B splice variant of fibronectin.

Mechanism
Curator reviewed
Code names
PYX-201

Resolves to

Targets
P02751FN1

What you can answer from here — as of October 26, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with PYX-201, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In